UPDATE 1-U.S. FDA approves Vertex cystic fibrosis combination treatment
February 12, 2018 at 17:59 PM EST
Feb 12 (Reuters) - The U.S. Food and Drug administration on Monday approved a treatment for cystic fibrosis that combines Vertex Pharmaceuticals Inc's Kalydeco with another medicine, Vertex said, marking the company's third product for the life-shortening lung disorder.